AdhereHealth Launches COVID-19 Adherence Solution

NASHVILLE, Tenn., May 5, 2020 /PRNewswire/ — AdhereHealth today announced the immediate availability of its new COVID-19 Adherence Solution, an innovative program that combines comprehensive predictive analytics and tech-enabled consumer outreach with home-delivered pharmacy services to support the Coronavirus crisis response.

COVID-19 has exacerbated existing social determinant of health (SDOH) issues and medication adherence challenges for underserved populations. Statistics show almost 90% of those who are hospitalized with the virus have underlying conditions, and a majority are over the age of 50.

“There’s real-world evidence that shows medication non-adherence is driving more COVID-19 hospitalizations,” said Jason Z. Rose, CEO of AdhereHealth. “By proactively targeting high-risk populations we can help keep more consumers adherent and healthy, and reduce the risk of becoming seriously ill from the virus.”

AdhereHealth’s COVID-19 Adherence Solution program helps improve health outcomes for at risk populations by enabling health plans and employers with:

  • Comprehensive predictive analytics to identify populations at higher risk of medication non-adherence
  • Support from a team of nationwide employed licensed clinicians who provide direct omni-channel consumer and provider engagement to discuss health status and coordinate care
  • Data-driven outreach designed to resolve SDOH issues in the context of COVID-19 using available health plan benefits and community resources
  • Private-couriered medication delivery services catering to vulnerable populations

“In normal times, a staggering 50% of patients who are managing chronic conditions don’t take their medications as directed. Factor in continued lockdowns, social distancing and economic hardships  – and it’s easy to see how non-adherence is likely to get worse. Engaging with consumers proactively gives us a chance to get them support before they wind up in a hospital bed.” 

To learn more about AdhereHealth’s Technology and Value-Based Pharmacy Innovation, visit: https://adherehealth.com/technology-and-value-based-pharmacy-innovation/

About AdhereHealth
AdhereHealth is a healthcare technology solutions leader supporting health plans, self-insured employers, and other risk-bearing entities for medication adherence insights and improved healthcare outcomes. The company’s Adhere™ platform touches nearly 30 million consumers through advanced technologies and at-risk engagement services. AdhereHealth’s subsidiary company, AdhereRx, is a pharmacy for complex patients with high-risk chronic conditions and social determinants of health issues. AdhereRx coordinates complex medication regimens with providers, performs monthly comprehensive medication reviews (CMR) and drug utilization reviews (DUR), has 24/7 access to pharmacy clinicians, delivers prescriptions via a private courier service, supports those in need of financial assistance, and can take cash on delivery at the consumer’s home. This integrated set of solutions addresses an estimated half a trillion dollars of unnecessary annual medical costs attributed to medication adherence issues. The company is headquartered in the Nashville suburb of Franklin, Tennessee. For more information, please visit www.adherehealth.com.

Media Contact:
Andrea LePain
eMedia Junction
andrea@emediajunction.com
617-894-1153

View original content to download multimedia:http://www.prnewswire.com/news-releases/adherehealth-launches–covid-19-adherence-solution-301053121.html

SOURCE AdhereHealth

Staff

Recent Posts

CENTR Brands Corp. Appoints Director & New Chief Executive Officer

Vancouver, British Columbia--(Newsfile Corp. - March 28, 2024) - CENTR Brands Corp. (CSE: CNTR) (FSE:…

8 hours ago

Haven Health Care Announces Achievement of Expansion

BOCA RATON, FL / ACCESSWIRE / March 28, 2024 / Haven Health Care Services, a…

9 hours ago

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences

BOULDER, CO / ACCESSWIRE / March 28, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global…

12 hours ago

LFTD Partners Inc. to Host Fourth Quarter and Full Year 2023 Earnings Conference Call on April 1, 2024

JACKSONVILLE, FL / ACCESSWIRE / March 28, 2024 / LFTD Partners Inc. ("LFTD Partners" or…

12 hours ago

Unify Medical Announces Todd Rasmussen, MD, as Special Consultant for Its Military Initiatives

Unify Medical, Inc., a privately held, smart surgical visualization technology company, announced the appointment of…

15 hours ago

Empathic Podiatry Selects eClinicalWorks Cloud EHR, Revenue Cycle Management and Robotic Process Automation to Improve Efficiency

Texas-based specialty practice chooses eClinicalWorks Cloud EHR to increase automation, streamline workflows, and enhance patient…

18 hours ago